Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Overview
The symptoms of amyotrophic lateral sclerosis include difficulty breathing, difficulty swallowing, head drop due to weakness of the neck muscles, muscle cramps, speech problems, such as a slow or abnormal speech pattern (slurring of words), voice changes, hoarseness, weight loss.
The Amyotrophic Lateral Sclerosis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Segmentation by Targets
The key targets in the Amyotrophic Lateral Sclerosis pipeline drugs market are TAR DNA Binding Protein 43, Superoxide Dismutase [Cu-Zn], Free Radical, Guanine Nucleotide Exchange C9orf72, Macrophage Colony Stimulating Factor 1 Receptor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase, Apoptosis Regulator BAX, Kelch Like ECH Associated Protein 1, Ataxin 2, BDNF/NT 3 Growth Factors Receptor, and others.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Analysis by Targets
For more target insights into the Amyotrophic Lateral Sclerosis pipeline Drugs market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Amyotrophic Lateral Sclerosis pipeline products market are TAR DNA Binding Protein 43 Inhibitor, Superoxide Dismutase [Cu-Zn] Inhibitor, Free Radical Scavenger, Guanine Nucleotide Exchange C9orf72 Inhibitor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase Inhibitor, Apoptosis Regulator BAX Inhibitor, Kelch Like ECH Associated Protein 1 Inhibitor, BDNF/NT 3 Growth Factors Receptor Agonist, Glial Cell Line Derived Neurotrophic Factor Activator, Interleukin 10 Activator, and others.
Amyotrophic Lateral Sclerosis Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Amyotrophic Lateral Sclerosis pipeline products market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Amyotrophic Lateral Sclerosis pipeline drugs market are oral, intravenous, intrathecal, subcutaneous, parenteral, intramuscular, sublingual, topical, inhalational, intraarticular, and others.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Analysis by Routes of Administration
For more routes of administration insights into the Amyotrophic Lateral Sclerosis pipeline Drugs market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Amyotrophic Lateral Sclerosis pipeline products market are small molecule, gene therapy, cell therapy, monoclonal antibody, antisense oligonucleotide, synthetic peptide, recombinant protein, biologic, protein, antisense RNAi oligonucleotide, fusion protein, and others.
Amyotrophic Lateral Sclerosis Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Amyotrophic Lateral Sclerosis pipeline products market, download a free report sample
Competitive Landscape
Some of the leading players in the Amyotrophic Lateral Sclerosis pipeline drugs market are Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, and Treeway BV.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Analysis by Players
To know more about the leading players in the Amyotrophic Lateral Sclerosis pipeline drugs market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Products Market Report Overview
| Key Targets | TAR DNA Binding Protein 43, Superoxide Dismutase [Cu-Zn], Free Radical, Guanine Nucleotide Exchange C9orf72, Macrophage Colony Stimulating Factor 1 Receptor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase, Apoptosis Regulator BAX, Kelch Like ECH Associated Protein 1, Ataxin 2, BDNF/NT 3 Growth Factors Receptor, and Others |
| Key Mechanisms of Action | TAR DNA Binding Protein 43 Inhibitor, Superoxide Dismutase [Cu-Zn] Inhibitor, Free Radical Scavenger, Guanine Nucleotide Exchange C9orf72 Inhibitor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase Inhibitor, Apoptosis Regulator BAX Inhibitor, Kelch Like ECH Associated Protein 1 Inhibitor, BDNF/NT 3 Growth Factors Receptor Agonist, Glial Cell Line Derived Neurotrophic Factor Activator, Interleukin 10 Activator, and Others |
| Key Routes of Administration | Oral, Intravenous, Intrathecal, Subcutaneous, Parenteral, Intramuscular, Sublingual, Topical, Inhalational, Intraarticular, and Others |
| Key Molecule Type | Small Molecule, Gene Therapy, Cell Therapy, Monoclonal Antibody, Antisense Oligonucleotide, Synthetic Peptide, Recombinant Protein, Biologic, Protein, Antisense RNAi Oligonucleotide, Fusion Protein, and Others |
| Leading Players | Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, Treeway BV, and Others |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Amyotrophic Lateral Sclerosis (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Amyotrophic Lateral Sclerosis (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Amyotrophic Lateral Sclerosis (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Amyotrophic Lateral Sclerosis (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Amyotrophic Lateral Sclerosis (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Amyotrophic Lateral Sclerosis (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The key targets in the Amyotrophic Lateral Sclerosis pipeline products market are TAR DNA Binding Protein 43, Superoxide Dismutase [Cu-Zn], Free Radical, Guanine Nucleotide Exchange C9orf72, Macrophage Colony Stimulating Factor 1 Receptor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase, Apoptosis Regulator BAX, Kelch Like ECH Associated Protein 1, Ataxin 2, BDNF/NT 3 Growth Factors Receptor, and others.
The key mechanisms of action in the Amyotrophic Lateral Sclerosis pipeline products market are TAR DNA Binding Protein 43 Inhibitor, Superoxide Dismutase [Cu-Zn] Inhibitor, Free Radical Scavenger, Guanine Nucleotide Exchange C9orf72 Inhibitor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase Inhibitor, Apoptosis Regulator BAX Inhibitor, Kelch Like ECH Associated Protein 1 Inhibitor, BDNF/NT 3 Growth Factors Receptor Agonist, Glial Cell Line Derived Neurotrophic Factor Activator, Interleukin 10 Activator, and others.
The key routes of administration in the Amyotrophic Lateral Sclerosis pipeline products market are oral, intravenous, intrathecal, subcutaneous, parenteral, intramuscular, sublingual, topical, inhalational, intraarticular, and others.
The key molecule types in the Amyotrophic Lateral Sclerosis pipeline products market are small molecule, gene therapy, cell therapy, monoclonal antibody, antisense oligonucleotide, synthetic peptide, recombinant protein, biologic, protein, antisense RNAi oligonucleotide, fusion protein, and others.
Some of the leading players in the Amyotrophic Lateral Sclerosis pipeline products market are Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, and Treeway BV.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Central Nervous System reports